An Act to create 77.51 (9rm) and 77.54 (14) (g) of the statutes; Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE)
Impact
The implementation of this sales tax exemption is expected to have a positive impact on state laws concerning consumer sales taxes. It aims to reduce the cost of essential healthcare products for residents, potentially increasing access to necessary medications. The measure is deemed beneficial in promoting health equity and affordability, especially for lower-income households who may struggle with out-of-pocket expenses related to healthcare products.
Summary
Senate Bill 1032 aims to provide a sales and use tax exemption specifically for the sale of over-the-counter drugs in Wisconsin. The bill defines 'over-the-counter drug' in accordance with federal regulations, ensuring that products eligible for the exemption are clearly labeled with necessary information about active ingredients and formulations. By instituting this exemption, the bill seeks to alleviate some financial burdens on consumers who purchase these health-related items, thereby promoting public health and accessibility.
Contention
One point of contention surrounding Senate Bill 1032 may arise from the fiscal implications of enacting such tax exemptions. Critics may argue that while the bill aims to support consumers, it could lead to a decrease in state revenue from sales taxes, which could affect funding for public services. Additionally, there may be concerns regarding how the bill delineates the types of drugs that qualify for the exemption, potentially leading to debates over specific product categories.
Crossfiled
An Act to create 77.51 (9rm) and 77.54 (14) (g) of the statutes; Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE)